When does Valneva report earnings and how will it affect VLA.PA stock?

Valneva will report FY2025 results on 18 March 2026. The report can move VLA.PA stock on sales for IXIARO and DUKORAL, R&D spend, and cash flow guidance. Expect volatility around the webcast and guidance comments.

What price targets and forecasts exist for VLA.PA stock?

Meyka AI projects a central 12-month price of €5.04 (+2.26%), a bullish quarterly scenario €5.73 (+16.23%) and a near-term bearish €3.86 (-21.70%). These are model projections and not guarantees.

Is Valneva overvalued versus its sector for VLA.PA stock?

On price-to-book, VLA.PA at 5.32 is above the Healthcare sector PB near 2.64, indicating a premium. Negative margins and EPS -0.65 underline the valuation risk until profitability improves.

What are the top catalysts to watch for VLA.PA stock after earnings?

Key catalysts include management guidance on cash flow, reported vaccine sales trends, and clinical updates for VLA15 and VLA1553. Funding plans or partnerships could also change the outlook materially.

EU Stocks

€4.93 pre-market VLA.PA Valneva SE EURONEXT 11 Mar 2026 earnings: catalysts

ByHuzaifa Zahoor March 11, 2026March 11, 2026

VLA.PA stock opens pre-market at €4.93 as investors position ahead of Valneva SE’s full-year 2025 results and webcast scheduled for 18 March 2026. Trading shows 2,726,316.00 shares today vs average volume 989,633.00, signaling higher interest. Key near-term drivers include FY2025 revenue and margin detail, cash runway commentary, and clinical updates on VLA15 and VLA1553 that can move sentiment in EUR on the EURONEXT market.